Detalles de la búsqueda
1.
Impact of Perioperative Systemic Chemotherapy on Survival for Patients Who have Diffuse Malignant Peritoneal Mesothelioma Treated with CRS-HIPEC.
Ann Surg Oncol
; 31(1): 556-566, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37940804
2.
2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer.
Ann Surg Oncol
; 31(1): 567-576, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37940803
3.
2022 PSOGI Consensus on HIPEC Regimens for Peritoneal Malignancies: Diffuse Malignant Peritoneal Mesothelioma.
Ann Surg Oncol
; 30(12): 7803-7813, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37481492
4.
The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Methodology.
Ann Surg Oncol
; 30(4): 2508-2519, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36595113
5.
Relapse of Pseudomyxoma Peritonei After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Pattern of Failure, Clinical Management and Outcomes.
Ann Surg Oncol
; 30(1): 404-414, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36094689
6.
HIPEC Methodology and Regimens: The Need for an Expert Consensus.
Ann Surg Oncol
; 28(13): 9098-9113, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34142293
7.
Impact of Previous Gynecologic Surgical Procedures on Outcomes of Non-Gynecologic Peritoneal Malignancies Mimicking Ovarian Cancer: Less Is More?
Ann Surg Oncol
; 28(5): 2899-2908, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33641011
8.
Prognostic Impact of Primary Side and RAS/RAF Mutations in a Surgical Series of Colorectal Cancer with Peritoneal Metastases.
Ann Surg Oncol
; 28(6): 3332-3342, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32974694
9.
Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS).
Ann Surg Oncol
; 27(1): 98-106, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31691116
10.
A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer.
Int J Mol Sci
; 21(13)2020 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32646060
11.
ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma treated with CRS-HIPEC.
Ann Surg Oncol
; 31(4): 2511-2512, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38219000
12.
Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.
J Surg Oncol
; 119(3): 336-346, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30554404
13.
Molecular Signatures for Combined Targeted Treatments in Diffuse Malignant Peritoneal Mesothelioma.
Int J Mol Sci
; 20(22)2019 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31752449
14.
Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Ann Surg Oncol
; 25(2): 404-413, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29159742
15.
Dose-Dependent Effect of Red Blood Cells Transfusion on Perioperative and Long-Term Outcomes in Peritoneal Surface Malignancies Treated with Cytoreduction and HIPEC.
Ann Surg Oncol
; 25(11): 3264-3270, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30051371
16.
ASO Author Reflections: International Standardization of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocols-Malignant Peritoneal Mesothelioma as a Model.
Ann Surg Oncol
; 30(12): 7858-7859, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37626249
17.
ASO Visual Abstract: 2022 PSOGI Consensus on HIPEC Regimens for Peritoneal Malignancies-Diffuse Malignant Peritoneal Mesothelioma.
Ann Surg Oncol
; 30(12): 7867-7868, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37624515
18.
Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series.
Ann Surg Oncol
; 25(4): 878-884, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29270877
19.
Correction to: Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series.
Ann Surg Oncol
; 25(Suppl 3): 987, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29352430
20.
Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry.
Ann Surg Oncol
; 25(3): 667-673, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29260418